Fresenius SE Research and Development Expenses 2016-2025 | FSNUY
Fresenius SE research and development expenses from 2016 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
Fresenius SE Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$694 |
| 2023 |
$715 |
| 2022 |
$913 |
| 2021 |
$952 |
| 2020 |
$858 |
| 2019 |
$722 |
| 2018 |
$795 |
| 2017 |
$631 |
| 2016 |
$553 |
| 2015 |
$515 |
Fresenius SE Quarterly Research and Development Expenses
(Millions of US $) |
| 2025-03-31 |
$147 |
| 2024-12-31 |
$189 |
| 2024-09-30 |
$187 |
| 2024-06-30 |
$167 |
| 2024-03-31 |
$151 |
| 2023-12-31 |
$99 |
| 2023-09-30 |
$185 |
| 2023-06-30 |
$219 |
| 2023-03-31 |
$213 |
| 2022-12-31 |
$287 |
| 2022-09-30 |
$211 |
| 2022-06-30 |
$215 |
| 2022-03-31 |
$201 |
| 2021-12-31 |
$237 |
| 2021-09-30 |
$254 |
| 2021-06-30 |
$237 |
| 2021-03-31 |
$224 |
| 2020-12-31 |
$242 |
| 2020-09-30 |
$193 |
| 2020-06-30 |
$218 |
| 2020-03-31 |
$205 |
| 2019-12-31 |
$170 |
| 2019-09-30 |
$225 |
| 2019-06-30 |
$154 |
| 2019-03-31 |
$174 |
| 2018-12-31 |
$217 |
| 2018-09-30 |
$185 |
| 2018-06-30 |
$198 |
| 2018-03-31 |
$195 |
| 2017-12-31 |
$212 |
| 2017-09-30 |
$155 |
| 2017-06-30 |
$134 |
| 2017-03-31 |
$129 |
| 2016-12-31 |
$156 |
| 2016-09-30 |
$142 |
| 2016-06-30 |
$131 |
| 2016-03-31 |
$125 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$23.628B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
